Department of Medicine
Faculty Profiles by Division

Division of Gastroenterology, Hepatology and Nutrition

Faculty Profiles

[Return To Index page]
photo Jing Hu, PhD


Associate Professor of Medicine


Phone: 412-623-2227

Office: 5117 Centre Ave.
Hillman Cancer Center, Suite 2.27
Pittsburgh, PA 15231
Phone: 412-623-2227
Education and Training
PhD, Inst. of Environmental Medicine, Karolinska Inst., Stockholm, Sweden, 1997
Cancer Research, CRTA Fellow, Laboratory of Cancer Prevention, National Cancer Gene Inst., Frederick, MD, 2005
Postdoctoral Scientist, Div. of Pulmonary & Critical Care Medicine, New York Univ. Sch. of Medicine, New York, NY, 2001
Postdoctoral Fellow, Dept. of Molecular & Cellular Pharmacology, Univ. of Miami Miller School of Medicine, Miami, FL, 1998
Research Interest
Molecular Mechanisms Underlying Disease Progression of Serrated Colorectal Cancer: using genetically engineered mouse models of colorectal cancers (CRC), Dr. Hu's lab focuses on the identification and validation of crucial molecular changes that confer high-risk for tumor progression in mutant BRAF-induced serrated intestinal tumorigenesis. Her lab works to identify novel factors essential for serrated CRC development that can serve as pharmacological targets for the prevention of serrated CRC at an early and curable stage.

Novel Approaches for the Intervention of Pancreatic Cancer: Dr. Hu's lab also works to identify and validate novel functionally relevant and druggable targets for PDAC.
Educational Interest
Dr. Hu is committed to medical science education for GI fellows, residents, medical students, and interested trainees in research pathways. Dr. Hu teaches in the University of Pittsburgh Department of Pharmacology and Chemical Biology, and she welcomes mentorship of research trainees.
For my complete bibliography, Click Here.
Selected Publications:
Hu J, Straub J, Xiao D, Singh SV, Yang HS, Sonenberg N, Vatsyayan J. Phenethyl Isothiocyanate, A Caner Chemopreventive Constituent of Cruciferous Vegetables, Inhibits Cap-Dependent Translation by Regulating the Level and Phosphorylation of 4E-BP1. Cancer Res. 2007; 67(8): 3569-73.
Vatsyayan J, Qing GL, Xiao G, Hu J. SUMO-1 Modification of NF-kB2/p100 is Essential for Stimuli-Induced p100 Phosphorylation and Processing. EMBO Reports. 2008; 9(9): 885-90.
Xiang X, Vatsyayan J, Gao C, Bakkenist C, Hu J. Sumoylation of eIF4E Activates mRNA Translation. EMBO Reports. 2010; 11(4): 299-304.
Xu X, Vatsyayan J, Gao C, Bakkenist CJ, Hu J. HDAC2 Promotes eIF4E Sumoylation and Activates mRNA Translation Gene Specifically. J Biol Chem. 2010; 285(24): 18139-43.
Gao C, Chen G, Romero G, Moschos S, Xu X, Hu J. Induction of Gsk3B Ubiquitination is Required for the Activation of the Wnt/B-catenin Pathway. J Biol Chem. 2014; 289(10): 7099-108.
Gao C, Chen G, Kuan S-F, Zhang DH, Schlaepfer DD, Hu J. FAK/PYK2 Promotes the Wnt/B-catenin Pathway and Intestinal Tumorigenesis by Phosphorylating GSK3B. eLife. 2015; 10: 11072.
Chen G, Gao C, Gao X, Zhang DH, Kuan SF, Burns TF, Hu J. Wnt/B-catenin Pathway Activation Mediates Adaptive Resistance to BRAF Inhibition in Colorectal Cancer. Mol Cancer Ther. 2018; 17(4): 806-13.
Gao C, Hu J. Targeting Parallel Bypass Signaling to Combat Adaptive Resistance to BRAF Inhibition in Colorectal Cancer. Oncoscience. 2018; 5(3-4).
Gao C, Chen G, Zhang DH, Zhang J, Kuan SF, Hu W, Esni F, Gao X, Guan JL, Chu E, Hu J. PYK2 is Involved in Premalignant Acinar Cell Reprogramming and Pancreatic Ductal Adenocarcinoma Maintenance by Phosphorylating B-catenin Y654. Cell Mol Gastroenterol. 2019.
Tandon M, Coudriet GM, Criscimanna A, Socorro M, Eliliwi M, Singhi AD, Cruz-Monserrate Z, Bailey P, Lotze MT, Zeh H, Hu J, Goffin V, Gittes GK, Biankin AV, Esni F. Prolactin Promotes Fibrosis and Pancreatic Cancer Progression. Cancer Res. 2019; 79(20): 5316-27.
Notable Achievements
Hillman Fellow - Hillman Foundation, Pittsburgh, PA, 2006-2009
Award for Research Excellence - National Cancer Inst., Frederick, MD, 2005
Cancer Research Training Award - National Cancer Inst., Frederick, MD, 2002-2005